The past 5–10 years have brought in a new era in the care of patients with thyroid
cancer, with the introduction of transformative diagnostic and management options.
Several international ultrasound-based thyroid nodule risk stratification systems
have been developed with the goal of reducing unnecessary biopsies. Less invasive
alternatives to surgery for low-risk thyroid cancer, such as active surveillance and
minimally invasive interventions, are being explored. New systemic therapies are now
available for patients with advanced thyroid cancer.